Yamazaki, K., Inagaki, N., Moldaver, D., Viana, R., & Kimura, S. (2020). Budget impact analysis of treatment‐free remission in nilotinib‐treated Japanese chronic myeloid leukemia patients. Cancer Sci.
Citação norma ChicagoYamazaki, Kiyotaka, Naohito Inagaki, Daniel Moldaver, Ricardo Viana, and Shinya Kimura. "Budget Impact Analysis of Treatment‐free Remission in Nilotinib‐treated Japanese Chronic Myeloid Leukemia Patients." Cancer Sci 2020.
ציטוט MLAYamazaki, Kiyotaka, et al. "Budget Impact Analysis of Treatment‐free Remission in Nilotinib‐treated Japanese Chronic Myeloid Leukemia Patients." Cancer Sci 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.